| SCHRODER ISF FRONTIER MARKETS EQUITY A ACC USD | RVI EMERGENTES | 291,542074 | 19/02/2026 | 8,31% | 77,69% | ***** |
| SCHRODER ISF FRONTIER MARKETS EQUITY A CAP SGD | RVI EMERGENTES | 113,804304 | 19/02/2026 | 8,24% | 77,68% | ***** |
| JPM US TECHNOLOGY A (ACC) EUR | TMT | 1.012,400000 | 19/02/2026 | -7,42% | 77,64% | **** |
| SCHRODER ISF FRONTIER MARKETS EQUITY A ACC SEK | RVI EMERGENTES | 275,506271 | 19/02/2026 | 8,04% | 77,64% | ***** |
| AB SICAV I-GLOBAL VALUE PORTFOLIO S GBP H | RVI GLOBAL VALOR | 42,275120 | 19/02/2026 | 9,08% | 77,59% | ***** |
| MAN JAPAN COREALPHA EQUITY I GBP | RVI JAPÓN | 494,910591 | 18/02/2026 | 16,04% | 77,49% | **** |
| JANUS HENDERSON HF - BIOTECHNOLOGY A2 USD | BIOTECNOLOGÍA | 30,596443 | 19/02/2026 | 0,37% | 77,45% | ***** |
| BGF US GROWTH A2 EUR (HEDGED) | RVI USA CRECIMIENTO | 39,020000 | 19/02/2026 | -3,94% | 77,44% | **** |
| MAN JAPAN COREALPHA EQUITY I EUR | RVI JAPÓN | 435,960000 | 18/02/2026 | 16,19% | 77,40% | *** |
| FIDELITY FUNDS-EMERGING EUROPE, MIDDLE EAST AND AFRICA A-ACC-USD | RVI EMERGENTES | 17,246660 | 19/02/2026 | 9,60% | 77,39% | ***** |
